University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Location status: Recruiting
NCT Number: NCT06811896
Women living with HIV have 2-4x higher risk for cardiovascular disease compared to women without HIV, with women living with HIV in the Southern US being particularly at risk. While an increased prevalence of traditional risk factors (e.g., hypertension, diabetes, and obesity) partially explain this risk, evidence suggests that increased exposure to structural and social stressors (e.g., poverty, discrimination, and stigma) among women living with HIV in the South negatively contribute to cardiovascular disease disparities through their impact on stress. The Stress Management and Resiliency Training (SMART) program is an effective, evidence-based intervention proven to improve resiliency to environmental stressors and reduce the physiologic responses to stress which contribute to cardiovascular disease. While the SMART program has demonstrated efficacy in a wide range of populations and settings, it has not been designed for or tested among women living with HIV in the South, where unique cultural and faith-based context may diminish the uptake and value of the intervention to mitigate cardiovascular disease risk. The purpose of this study is to adapt the evidence-based SMART program in consideration of the needs and contexts of women living with HIV in the Southern US and pilot the adapted intervention to establish the feasibility, acceptability, and preliminary impact of the adapted intervention to reduce stress and mitigate cardiovascular disease risk among this population.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Birmingham, Alabama, 35294, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Stress Management and Resiliency Training Intervention is an evidence-based intervention to reduce physiologic responses to stress that may contribute to cardiovascular disease risk. The intervention is typically delivered over an 8-week period and works to decrease stress responses by improving psychological resiliency to structural and social stressors and decreasing sympathetic nervous system activation. Eliciting the relaxation response through meditation, mindfulness, and autogenic training are core components.
Usual social and clinical services provided to patients at the recruiting clinic
Time frame: baseline - week 8 - week 20
Measure blood pressure at baseline, end of intervention, and at 12-week follow-up
Time frame: baseline - week 8 - week 20
Higher score indicates more depressive symptoms (0-60 Range)
Time frame: baseline - week 8 - week 20
Higher scores indicate greater symptoms of anxiety (0-21 Range)
Time frame: baseline - week 8 - week 20
Higher scores indicate greater perceived stress (0 - 40 Range)
Time frame: baseline - week 8 - week 20
Higher scores indicate greater resilience (0-100 Range)
Contact information is provided by the study sponsor or research team.
University of Alabama at Birmingham
Other
Adapting and Piloting a Stress Management Intervention to Reduce Cardiovascular Disease Risk Among Women Living With HIV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07717723
Anxiety, Anxiety Disorders
Sacramento, California, United States
View Trial DetailsNCT07319117
Anxiety, Anxiety Disorders
Leeds, West Yorkshire, United Kingdom
View Trial DetailsNCT06283069
Behavior, Cardiovascular Diseases
Milan, Italy
View Trial DetailsNCT06968650
Behavior, Behavioral Symptoms
Miami, Florida, United States
View Trial Details